The Safety of anti-VEGF Therapy

Article

Under the microscope, in trials and in clinical practice...

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Related Content
Three ways we’re building confidence through evidence in myopia management

Three ways we’re building confidence through evidence in myopia management

July 25th 2025
Article
Site Logo

Updates From Angiogenesis-2022

February 11th 2022
Podcast
Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?

Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?

July 17th 2025
Article
Site Logo

Updates from ASRS 2021

October 28th 2021
Podcast
Site Logo

A Turning Point in Retinal Neovascular Diseases

Sponsored by Bayer
April 11th 2025
Article
Clinical outcomes and patient satisfaction achieved with a corneal approach for managing presbyopia – a case with special significance

Clinical outcomes and patient satisfaction achieved with a corneal approach for managing presbyopia – a case with special significance

Arnaldo Espaillat, MD
April 1st 2025
Article

Dr. Arnaldo Espaillat decided to undergo ZEISS PRESBYOND and shares how his own experience led him to expand his refractive portfolio with this corneal-based approach for patients without cataracts.

© 2025 MJH Life Sciences

All rights reserved.